Additional information
Yellow Powder
59-30-3
ACI-060700
224.4ºC(decompose)
C19H19N7O6
441.4
Ambient
2-8°C
Anticancer
Pharmaceutical Impurity Standards
(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl) methyl] amino]benzoyl] amino]pentanedioic acid
(2S)-2-[[4-[[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoyl]amino]pentanedioic acid
Folic Acid;N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic Acid





![BUTOXYQUINOLINONE BREXPIPRAZOLE (25 mg) (7-[4-(7-{4-[4-(Benzo[b]thiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2-yloxy)butoxy]quinolin-2(1H)-one)](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)